TP53 and cancer: As seen in most cancer cell lines expressing wild type p53, MDM2 inhibition with nutlin stabilizes p53 but does not suffice to cause p53-dependent apoptosis in TPC1 or K1 cells (Fig. 1a, b and Supplementary Fig. 1a).